title: Contractility evaluation by 2 dimensional echocardiography and gated SPECT myocardial perfusion scintigraphy in hypertensive patients with clinical presentation of atypical chest pain.
abstract: BACKGROUND
  Hypertension (HT) is a growing health problem in the population and associated with increased cardiovascular event risk and mortality. In hypertensive patients, progressive left ventricular (LV) contractility deterioration is detectable by gated single photon emission computed tomography (SPECT) myocardial perfusion scintigraphy9. We planned this study to explore the agreement in ejection fraction (EF) determination between 2 dimensional echocardiography and gated SPECT analysis in selected group of patients with hypertension.
  
  
  METHODS
  We studied 26 consecutive patients (mean age 56.5 ± 8.8 years; 6 men) with hypertension. Quantitative contractility analysis by both echocardiography and SPECT at rest was performed to investigate the agreement between two diagnostic tests.
  
  
  RESULTS
  EF at rest was greater than 55 % in all patients. All patients had a clinical presentation of atypical chest pain. Therefore, in addition to quantitative contractility analysis at rest by echocardiography and myocardial SPECT perfusion scintigraphy, we examined ischemia by stress induction and determined that 10 patients had ischemic finding (38.4 %). The mean value of EF calculated by echocardiography was 67.5 ± 5.7 %, while EF by gated SPECT was 72.8 ± 8.5 %. We documented an acceptable agreement in EF determination between these 2 diagnostic tests by meaningful correlation (r = 0.556, p = 0.003). There was no regional contractility deterioration despite existence of ischemia in 10 patients of the study group.
  
  
  CONCLUSIONS
  We observed that both echocardiography and gated SPECT can be used for quantification of EF in the hypertensive patients with an acceptable agreement.
authors: H
authors: H
authors: Yalçin
authors: B
authors: B
authors: Karayalçin
authors: A
authors: A
authors: Boz
authors: B
authors: B
authors: Talay
authors: A
authors: A
authors: Belgi
authors: F
authors: F
authors: Yalçin
references: Ann Intern Med. 2003 Jan 7;138(1):10-6
references: 12513039
references: JAMA. 1999 Feb 17;281(7):634-9
references: 10029125
references: Nucl Med Commun. 2005 Feb;26(2):109-14
references: 15657502
references: Circulation. 1996 Jan 15;93(2):259-65
references: 8548897
references: Hypertension. 2010 Jan;55(1):1-8
references: 19933923
references: J Am Coll Cardiol. 2005 Oct 4;46(7):1270-5
references: 16198842
references: Ann Thorac Surg. 1995 Nov;60(5):1166-8
references: 8526594
references: Prog Cardiovasc Dis. 1969 Mar;11(5):371-90
references: 4892567
references: Int J Cardiol. 2010 Aug 6;143(1):e1-3
references: 19136173
references: J Am Coll Cardiol. 1996 Apr;27(5):1214-8
references: 8609345
references: Circ Heart Fail. 2010 May;3(3):420-30
references: 20176713
references: Am J Hypertens. 1995 Oct;8(10 Pt 1):1040-5
references: 8845073
references: J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
references: 2698218
references: Clin Med Res. 2005 May;3(2):75-82
references: 16012124
references: Circulation. 2003 Aug 5;108(5):560-5
references: 12847071
references: Vasc Health Risk Manag. 2008;4(5):1069-72
references: 19183754
references: Am J Cardiol. 1976 Jan;37(1):7-11
references: 1244736
references: Circulation. 2005 Aug 16;112(7):936-8
references: 16103249
references: Echocardiography. 2008 Apr;25(4):424-8
references: 18177389
references: Circulation. 1977 Apr;55(4):613-8
references: 138494
references: J Hum Hypertens. 2006 Aug;20(8):628-30
references: 16761028
references: J Hypertens. 2005 Oct;23(10):1817-23
references: 16148604
references: J Hypertens. 2005 Jul;23(7):1409-15
references: 15942465